Technological Advancement In Cosmetic Surgery Market
Cosmetic surgery is a unique discipline of medicine focused on enhancing appearance through surgical and medical techniques. Cosmetic surgery can be performed on all areas of the head, neck and body. Because treated areas function properly but lack aesthetic appeal, cosmetic surgery is elective. The most important thing is that the terms 'plastic surgery' and 'cosmetic surgery' are not interchangeable. Confusion about the terms has led to public misconceptions about the two specialties. Cosmetic surgery is the "surgery of appearance." It is elective and focuses on the aesthetics of beauty.
Explore More Insights@ https://www.alliedmarketresearch.com/request-sample/16865
The development of the worldwide cosmetic surgery market share is majorly driven by increase in prevalence of cosmetic surgical procedure; rise in demand for aesthetic procedure; and rise in technological advancement in healthcare sector. As per American Society of Plastic Surgeon, in 2020, it was accounted for that around 352,555 rhinoplasty technique are acted in U.S in 2020. It was dissected that the rhinoplasty was the main surgery acted in the U.S in 2020.
Technological development in the medical device industry to manufacture advanced cosmetic surgical products is expected to provide remunerative opportunities for expansion of the global cosmetic surgery market during the cosmetic surgery market forecast. Moreover, presence of key manufacturing companies to manufacture cosmetic surgery products and rise in expenditure on healthcare products propel growth of the market.
Key Market Players
· Abbvie Inc
· Bausch Health Companies Inc.
· Candela Syneron
· cynosure inc
· Galderma SA
· Merz Pharma GmbH and Co. KGaA
· Sientra Inc
· Sinclair Pharmaceuticals Limited
· Teoxane Laboratories
· Johnson and Johnson
According to a new report published by Allied Market Research, titled, “Cosmetic Surgery Market," The cosmetic surgery market size was valued at $67.3 billion in 2021, and is estimated to reach $201.0 billion by 2031, growing at a CAGR of 11.6% from 2022 to 2031.
North America accounted for a majority of the global cosmetic surgery market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to rise in number of breast augmentation procedures, increase in number of approvals for cosmetic surgery products, presence of cosmetic surgery industry, and advancements in healthcare, medical devices, and aesthetic sector in the region. Asia-Pacific is anticipated to witness lucrative growth, owing to increase in number of liposuctions, rise in awareness among young population regarding aesthetics, growth in health care expenditures, and rise in adoption of aesthetic products.
